This is an open access article published by the IET under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/)
Synthetic biology is transforming the ability to manufacture increasingly needed bio-based products in response to rising market demand. By applying engineering principles to the convolution of recent advances in genomic engineering techniques, information technology and automation, synthetic biology is facilitating the replacement of time-consuming ‘discover and grow’ approaches by more precise and affordable ‘biodesign and biomanufacture’ processes. Meantime, societal awareness of specific health, well-being, and environmental issues is increasing ‘market pull’ that will shape future pathways to commercialisation. Market interests will not only shape targets for product function and cost but also increasingly question their provenance. Sustainability concerns are already driving demand to replace petrochemical-derived by bio-derived products, but many established industries wishing to transition may lack familiarity with bio-manufacturing processes and with the wider issues associated with large-scale bio-feedstock supply chains. Meantime, commercialisation of synthetic biology today is being advanced mostly via start-ups and SMEs. Combining the knowledge and skills required to respond to market interests, as the scale of operations and complexity of issues expands, is likely to stimulate an increasing diversity of collaborative approaches.
References
-
-
1)
-
13. Policy Paper: ‘Bioeconomy strategy 2018 – 2030’. .
-
2)
-
35. Patel, P.: ‘Tech turns to biology as data storage needs explode’ (Scientific American, 2016). .
-
3)
-
29. Hardcastle, J.L.: ‘BASF, genomatica expand biochemical production’ (Environmental Leader, 2015). .
-
4)
-
20. National Research Council: ‘Industrialization of biology – a roadmap to accelerate the advanced manufacturing of chemicals’ (The National Academies Press, 2015), p. 46.
-
5)
-
6)
-
7)
-
8)
-
9)
-
10)
-
11)
-
6. Polizzi, K.M., Stanbrough, L., Heap, J.T.: ‘A new lease of life: understanding the risks of synthetic biology. An emerging risks report published by Lloyds of London report’, 2018.
-
12)
-
13)
-
10. Gleeson, A.: ‘The new synthesis’ (Biotechniques, 2018). .
-
14)
-
14. Weiss, R., Panke, S.: ‘Synthetic biology – paths to moving forward’, Curr. Opin. Biotechnol., 2009, 20, pp. 447–448.
-
15)
-
16)
-
17)
-
18)
-
41. Kansara, V.A.: ‘With lab-grown leather, modern meadow is engineering a fashion revolution’ (Business of Fashion, 2017). .
-
19)
-
20)
-
21)
-
22)
-
3. Clarke, L.J.: ‘Synthetic biology UK: progress, paradigms and prospects’, Eng. Biol., 2017, 1, (2), pp. 66–70.
-
23)
-
24)
-
40. Murray, J.: ‘From cell culture to table culture: food tech comes alive’, 26 June 2018. .
-
25)
-
23. Clarke, L.J.: ‘Biofuels in operation’, in Love, J., Bryant, J.A. (Eds.): ‘Biofuels and bioenergy’ (Wiley Blackwell, 2017), , pp. 21–44.
-
26)
-
27)
-
28)
-
29)
-
30)
-
21. ‘The bioeconomy to 2030: designing a policy agenda’ (OECD Publishing, 2009).
-
31)
-
32)
-
24. Lange, J.-P., Price, R., Ayoub, P.M., et al: ‘Valeric biofuels: a platform of cellulosic transportation fuels’, Angew. Chem. Int. Ed., 2010, 49, pp. 4479–4483.
-
33)
-
34)
-
35)
-
36)
-
37)
-
38)
-
39)
-
40)
-
5. Clarke, L.J., Kitney, R.I.: ‘Synthetic biology in the UK – an outline of plans and progress’, Synth. Syst. Biol., 2016, 1, pp. 243–257.
-
41)
-
2. Kuhn, T.S.: ‘The structure of scientific revolutions’ (University of Chicago Press, Chicago, 1962).
-
42)
-
43)
-
34. Le Feuvre, R.A., Scrutton, N.S.: ‘A living foundry for synthetic biological materials: a synthetic biology roadmap to new advanced materials’, Synth. Syst. Biotechnol., 2018, 3, (2), pp. 105–112.
http://iet.metastore.ingenta.com/content/journals/10.1049/enb.2018.5009
Related content
content/journals/10.1049/enb.2018.5009
pub_keyword,iet_inspecKeyword,pub_concept
6
6